Smruthi Organics Reports Strong Turnaround, ₹2.88 Cr Profit in Q1 FY27

Smruthi Organics' net profit stood at ₹2.88 crore in Q1 FY27, a significant improvement from a loss of ₹1.10 crore in Q1 FY26. Revenue from operations grew to ₹29.30 crore from ₹18.85 crore year-on-year.

Reader Takeaway: Profitability rebound driven by API focus; watch asset recovery and cost reallocation.

What just happened

Smruthi Organics Ltd. has reported a net profit of ₹2.88 crore for the first quarter of FY27 (ending June 30, 2026), compared to a net loss of ₹1.10 crore in the same quarter last year. Revenue from operations saw a substantial increase to ₹29.30 crore from ₹18.85 crore in Q1 FY26.

Why this matters

This marks a significant financial turnaround for the company, moving from a loss-making position to profitability. The revenue growth indicates a strong performance in its core business activities. The company has also strategically decided to operate as a pure-play API manufacturer by discontinuing its Formulations Marketing Division.

The backstory

The company has been restructuring its business. The Board of Directors approved the discontinuation of the Formulations Marketing Division, effective May 13, 2026. This division has been classified as a discontinued operation.

What changes now

Smruthi Organics is now solely focused on its Bulk Drugs and Intermediates (API) business. Following the discontinuation, unallocable costs and interest expenses have been reallocated to the API segment, which will now be the company's single operating segment.

Risks to watch

Investors should monitor the recovery of residual receivables from the discontinued Formulations Marketing Division, as there's a potential for delays or write-offs. Additionally, the impact of reallocated unallocable and interest costs on the API segment's future reported margins needs to be watched closely.

Peer comparison

[No verifiable peer comparison data available in the filing.]

Context metrics (time-bound)

• Q1 FY27 Revenue: ₹29.30 crore
• Q1 FY26 Revenue: ₹18.85 crore
• Q1 FY27 Net Profit: ₹2.88 crore
• Q1 FY26 Net Profit: (₹1.10 crore)

What to track next

Investors should track the progress of asset recovery from the discontinued operations and the impact of the expense reallocation on the API segment's profitability in upcoming quarters.